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To the Editor: Ethical controversy surrounds the issue of retention 
gifts in clinical trials and also the idea of remuneration for clinical 
trial participants. Some ethicists purport that retention gifts may 
influence a patient’s decision to participate in a clinical trial, either by 
persuading them to participate in a trial or by resisting discontinuation 
against their better judgement. These gifts may therefore represent 
undue inducement, defined as ‘the offer of an excessive, unwarranted, 
inappropriate or improper reward or other overture to obtain 
compliance’.1 This may potentially compromise the informed consent 
process, the patient’s health and the scientific validity of the trial, and 
is particularly relevant in a developing country such as South Africa, 
where vulnerable communities may be exploited.2-4 No guidance is 
provided on participant remuneration, when a gift may be undue, or 
what type of gift represents undue inducement in clinical trials.
Patient retention and keeping patients motivated in a clinical 
trial is a continuous process.5 Clinical trial participant drop-outs 
and those lost to follow-up after recruitment negatively affect study 
duration, cost and the generalising of study results, which may result 
in delaying a new agent’s regulatory approval.6 High drop-out rates 
also pose a risk to the interpretation and validity of the research 
findings.6 It is significantly more expensive to recruit a patient onto a 
clinical trial than to retain a patient in the trial.5 Despite the impact 
such drop-outs and loss to follow-up may have on a clinical trial’s 
final analysis, few pharmaceutical companies or clinical research 
organisations develop a formal retention plan with trial sites. For 
those that formulate such a plan, retention gifts often play an integral 
role, especially in long-term phase III trials. 
Objectives
Our objectives were to study clinical trial participants’ opinions on 
retention gifts and to ask patients to rate various retention gifts in 
order of preference.
Methods
This study was conducted by TREAD Research, a site-managed 
organisation based at Tygerberg Hospital, Western Cape, South 
Africa, and approved by the Research Development and Support 
Department of Stellenbosch University. Candidates were recruited 
from current trials conducted at the trial site, and written informed 
consent was obtained from all participants in their home language 
before asking them to complete the questionnaire in their home 
language. This comprised five questions requiring a ‘yes’ or ‘no’ 
answer. A sixth question asked patients to rate nine retention gifts in 
order of preference and to suggest additional retention gifts that they 
might find useful. All data were entered into an Excel spreadsheet and 
analysed using descriptive statistics.
Results
A total of 302 questionnaires were completed by voluntary 
participants. Fig. 1 presents the responses to questions 1 - 4 of the 
questionnaire.
Of the 302 respondents, 126 (41.7%) had previously received a 
retention gift. Of these, 64.3% said that the receipt of a gift did not 
influence them to stay on the trial and 69.0% responded that the 
quality of the gift did not affect their participation. 
Fig. 2 presents the participants’ ratings of the retention gifts. The 
most popular retention gift was a recipe book, followed by a cooler 
bag, an umbrella and a fleecy blanket. Suggestions for other gifts 
included a clock, a glucometer, a calculator and a key holder.
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Fig. 1. Participants’ responses to the questions: 1. Would the receipt of a re-
tention gift duri g a trial f l ng duration influence you to remain on the 
study? 2. Would the receipt of a gift cause you to tell others about clinical 
trials and the benefits of taking part in a trial? 3. If you knew before you 
signed consent that you were going to receive a gift, would this influence your 
decision to take part? 4. Would the fact that you are to receive a gift persuade 
you to stay on the study even if you wanted to withdraw from the trial?
The use of retention gifts in clinical trials has been controversial, 
with some ethicists maintaining that such gifts represent undue 
inducement to the trial participants. A study was conducted at 
TREAD Research, a site-managed organisation based at Tygerberg 
Hospital, in which 302 participants completed a questionnaire 
that focused on their opinion with regard to such gifts. The results 
suggest that these gifts do not influence patients to participate in a 
clinical trial or influence them to remain on a trial should they wish 
to withdraw. However, they do act as a useful motivational tool and 
trial participants appreciate them.
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Discussion
Our results suggest that, in this setting, the receipt of retention 
gifts does not influence patients to participate in a clinical trial or 
influence them to remain on a trial should they wish to withdraw. 
However, these gifts act as a useful motivational tool for studies of 
long duration, and trial participants appreciate them.
A study of patients’ motivations for participating in a trial7 
reported that access to medical care and making a contribution to 
scientific knowledge are common motivations for participation in 
cardiovascular clinical trials and that the role of remuneration is 
relatively unimportant. This sentiment is reflected in our findings 
regarding retention gifts. Most participants responded that receiving 
a retention gift would not influence their decision to participate in a 
clinical trial or influence them to remain on a trial should they wish 
to withdraw. 
However, our results suggest that retention gifts in this setting 
function as a motivational tool and are appreciated by trial 
participants. Most respondents indicated that the receipt of such a 
gift would influence them to remain on a study and that they would 
share this fact with others. Most studies conducted at this trial unit 
are long-term, phase III cardiovascular trials where patients often 
remain on a single study for up to 5 years. The receipt of a retention 
gift, which is often useful (e.g. a blanket or cooler bag) or educational 
(e.g. a recipe book or pedometer), functions as a critical motivational 
tool for participants. Understanding the underlying motivators for 
each patient is the first step to ensuring that their study expectations 
are met.5 
Of the 302 respondents, 126 (41.7%) had previously received a 
retention gift. Of these, 64.3% said that the receipt of a gift did not 
influence them to stay on the trial and 69.0% responded that the 
quality of the gift did not affect their participation. This is despite a 
study at this same trial site showing that the median (1st, 3rd quartile) 
reported hourly income of study participants was R10.23 (R4.10, 
R29.54).8
Conclusions
Generalisations regarding retention gifts for clinical trial 
participation are impossible. A ‘one size fits all’ approach to payment 
of trial participants is arguably injudicious,9 as is such an approach 
to providing retention gifts. Implemented and used appropriately in 
the correct setting, these gifts are useful motivational tools to retain 
patients on long-term clinical trials where minimising drop-out and 
lost-to-follow-up rates is imperative to ensure statistical validity and 
clinical applicability of the trial’s results.
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Retention gifts
 Natures pipe puffing
      Pristine plumes of dense white mist;
      Procrastinating.
 
      Gentle white blossom
      Innocent in early spring:
      Does not know the sun.
 
Haiku: Peter Folb 
SAMJ 100 years ago
SAMJ 100 years ago
